Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Research progresses of monoclonal antibodies therapy in neuromyelitis optica].
A case of acute combined central and peripheral demyelination.
Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis.
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Protein fibrillation and nanoparticle interactions: opportunities and challenges.
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Multiple sclerosis and infections.
The complex immunology of multiple sclerosis.
Psychiatric co-morbidity in multiple sclerosis: The risk of depression and anxiety before and after MS diagnosis.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
Identifying and addressing unmet therapeutic needs in MS.
Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.
MOG-IgG in neuromyelitis optica.
Quantitative metabolic profiling of lipid mediators.
Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version.
Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis.
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Tried-and-True Antibiotic May Block Conversion to MS
[Present and future of the transcranial magnetic stimulation].
Vitamin d assays: past and present debates, difficulties, and developments.
Abnormal brain iron metabolism in irp2 deficient mice is associated with mild neurological and behavioral impairments.
Painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
Pages
« first
‹ previous
…
333
334
335
336
337
338
339
340
341
…
next ›
last »